McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
45,000
Employees45,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
45,000
Employees45,000

MCK Key Statistics

Market cap
105.23B
Market cap105.23B
Price-Earnings ratio
26.80
Price-Earnings ratio26.80
Dividend yield
0.34%
Dividend yield0.34%
Average volume
781.74K
Average volume781.74K
High today
$867.38
High today$867.38
Low today
$849.62
Low today$849.62
Open price
$862.06
Open price$862.06
Volume
815.35K
Volume815.35K
52 Week high
$867.63
52 Week high$867.63
52 Week low
$558.13
52 Week low$558.13

Stock Snapshot

The current McKesson(MCK) stock price is $852.95, with a market capitalization of 105.23B. The stock trades at a price-to-earnings (P/E) ratio of 26.80 and offers a dividend yield of 34.3%.

As of 2025-11-19, McKesson(MCK) stock has fluctuated between $849.62 and $867.38. The current price stands at $852.95, placing the stock +0.4% above today's low and -1.7% off the high.

The McKesson(MCK)'s current trading volume is 815.35K, compared to an average daily volume of 781.74K.

During the past year, McKesson(MCK) stock moved between $558.13 at its lowest and $867.63 at its peak.

During the past year, McKesson(MCK) stock moved between $558.13 at its lowest and $867.63 at its peak.

MCK News

Simply Wall St 1d
How Strong Oncology Sales and Raised Guidance Could Shape McKesson’s Investment Narrative

McKesson Corporation recently reported strong second-quarter results, with sales rising to US$103.15 billion and net income reaching US$1.11 billion, driven by...

How Strong Oncology Sales and Raised Guidance Could Shape McKesson’s Investment Narrative

Analyst ratings

79%

of 19 ratings
Buy
78.9%
Hold
15.8%
Sell
5.3%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.